European Parliament Votes to Support Proposal for the Regulation of New Genomic Techniques
SAN DIEGO, Feb. 07, 2024 (GLOBE NEWSWIRE) — Cibus, Inc. (Nasdaq:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, welcomes the vote of the European Parliament on 7th February in favour of new legislation for New Genomic Techniques (NGTs). Cibus applauds the EU Parliament supporting a science-based approach developed following many years of discussion and engagement with stakeholders and expert groups.
Related news for (CBUS)
- Cibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize Fertilizer Use in Farming
- USDA Designates Cibus’ Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDA’s Biotechnology Regulations
- Cibus, Inc. Announces Pricing of $27.5 Million Public Offering
- Cibus, Inc. Announces Proposed Public Offering
- Cibus Reports First Quarter Financial Results and Provides Year-to-Date Business Update for 2025